版本:
中国

BRIEF-Neuroderm provides updates on ND0612 long-term safety trial

Sept 29 NeuroDerm Ltd :

* Neuroderm provides updates On ND0612 long term safety trial and submission of marketing applications

* Co's cash guidance remains unchanged,has sufficient cash to advance its product pipeline as planned,reach regulatory milestones through mid-2018 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐